May 11, 2017 by Chain Drug Review
Biotechnology Innovation Organization, commissioner of the Food and Drug Administration, FDA commissioner, Food and Drug Administration, Jim Greenwood, Lamar Alexander, Robert Califf, Scott Gottlieb, Stephen Ostroff, Tom Price, U.S. Department of Health and Human Services
Featured Articles, Leading Headlines, Pharmacy, Retail News
WASHINGTON — Dr. Scott Gottlieb has been sworn in as the new commissioner of the Food and Drug Administration. Gottlieb, nominated as FDA commissioner by President Donald Trump in March, took the helm as the FDA’s 23rd commissioner on Thursday after being confirmed by a vote of 57-42 in the Senate late Tuesday. He takes
February 24, 2016 by Chain Drug Review
FDA, FDA commissioner, Food and Drug Administration, Margaret Hamburg, Robert Califf, Stephen Ostroff, Sylvia Burwell
Leading Headlines, Pharmacy, Retail News
WASHINGTON — The U.S. Senate overwhelmingly confirmed Dr. Robert Califf as commissioner of the Food and Drug Administration. Califf, who was deputy commissioner for medical products and tobacco, was nominated as FDA commissioner by President Barack Obama in mid-September. No significant opposition was expected for his confirmation hearing on Tuesday, as the Senate voted 89-4
September 28, 2015 by Brian Bossetta and Chain Drug Review
Food and Drug Administration, Robert Califf, Stephen Ostroff
2015, Issue 09-28-2015, Issues, News
WASHINGTON — The Food and Drug Administration’s current deputy commissioner for medical products and tobacco is likely to become the organization’s next commissioner. Dr. Robert Califf, a cardiologist and clinical researcher long affiliated with Duke University, was nominated by President Obama earlier this month to head up the FDA. Though Califf must face Senate confirmation
September 16, 2015 by Chain Drug Review
Barack Obama, FDA commissioner, Food and Drug Administration, Margaret Hamburg, Robert Califf, Stephen Ostroff
Leading Headlines, Pharmacy, Retail News
WASHINGTON — The Food and Drug Administration’s current deputy commissioner for medical products and tobacco is likely to become the organization’s next commissioner. Dr. Robert Califf, a cardiologist and clinical researcher long affiliated with Duke University, on Tuesday was nominated as FDA commissioner by President Barack Obama. On Wednesday, his nomination was sent to the
June 16, 2015 by Chain Drug Review and Chain Drug Review
FDA, FDA’s Center for Food Safety and Applied Nutrition, Food and Drug Administration, food manufacturers, partially hydrogenated oils, PHOs, processed foods, Stephen Ostroff, Susan Mayne, trans fat
Leading Headlines, Supplier News
WASHINGTON — To eliminate trans fat in processed foods, the Food and Drug Administration has called on food manufacturers to remove partially hydrogenated oils (PHOs) from products over the next three years. The FDA said Tuesday that, following “a thorough review of the scientific evidence,” it has concluded that PHOs — the primary dietary source
February 16, 2015 by Mark Baumgartner and Chain Drug Review
Food and Drug Administration, Francis Collins, Generic Pharmaceutical Association, Margaret Hamburg, National Institutes of Health, Ralph Neas, Stephen Ostroff
2015, Issue 02-16-2015, News, Pharmacy
WASHINGTON — Dr. Margaret Hamburg, commissioner of the Food and Drug Administration, will step aside next month after nearly six years at the helm of the agency overseeing many of the nation’s most contentious public policy issues and products representing about 20% of every dollar spent by consumers. Hamburg, 59, said her decision to step
February 5, 2015 by Chain Drug Review
FDA, FDA commissioner, Food and Drug Administration, Margaret Hamburg, Stephen Ostroff
Pharmacy, Retail News
Margaret Hamburg WASHINGTON — Margaret Hamburg reportedly is stepping down as commissioner of the Food and Drug Administration. Published reports said Thursday that the 59-year-old Hamburg is slated to leave the FDA commissioner post at the end of March and that the Obama administration plans to make a formal announcement on Friday. Plans call for